Steroids News

  • Post Cycle Therapy (PCT)

    Post cycle therapy is a method of employing drugs which work via various mechanisms to go about trying to aid stabilizing and restoring a user's hormones back to normal once a suppressive anabolic androgenic steroid cycle has been ceased.

  • Patent For Innovative Nanoparticle

    British Dragon Pharma announced today that it has received a U.S. patent relating to its calcium phosphate nanoparticles (CAP). In addition to disclosing the compound itself, the new patent discloses methods of manufacture and use of CAP.

  • Transmucosal Insulin Administration

    British Dragon Pharma announced today that it presented pre-clinical data suggesting its transmucosal insulin can deliver significant dosages of insulin into the bloodstream

  • Significant Testabol Propionate Phase II Efficacy Results

    British Dragon Pharma announced new Testabol Propionate (bioidentical testosterone propionate) Phase II clinical trial efficacy data will be presented today at the annual meeting of the American Society for Reproductive Medicine (ASRM) in Philadelphia.

Steroids Tags

About Us

Steroids Articles

Privacy Policy

British Dragon Pharmacy is committed to respecting the privacy of visitors to its website. British Dragon will only collect your personal data, such as your name, address, telephone number, or email address, that is voluntarily submitted by you. BD and/or its agents will use this data solely to comply with any request for information, submission of relevant applications, or in a manner otherwise disclosed or authorized by you. BD will not sell, disclose or otherwise transfer your personal information submitted to this website to any third party unless otherwise requested or authorized by you.

Any non-personal communication, comments, ideas or material you post or transmit to British Dragon Pharmacy are, and will be treated as, non-confidential and non-proprietary. By transmitting or posting any communication or material to this website you grant to BD and all of its affiliates, an unrestricted, irrevocable license to use, reproduce, display, modify, transmit, distribute, publish, broadcast or post your communication for any purpose. You also agree that British Dragon is free to use any unsolicited ideas, concepts, know-how or techniques that you send us. However, we will not release your name or otherwise publicize the fact that you submitted materials or other information to us unless: (a) you grant us permission to do so; (b) we first notify you that the materials or other information you submit to a particular part of a site will be published or otherwise used with your name on it; or (c) we are required to do so by law.

As a resource to users, the British Dragon Pharma website may contain links to other sites that offer useful information. The privacy policies and procedures described here do not necessarily apply to those sites. For information on the privacy policies of individual sites, please contact those sites directly. BD does not assume responsibility for the content of those sites.

The British Dragon website may, on occasion, use a technology called 'cookies'. A cookie is a token that a server gives to your browser when you access a website. Cookies are capable of storing many types of data and help provide additional functionality to the site or to help us analyze site usage more accurately. In all cases in which cookies are used, we will not collect personally identifiable information except with your explicit permission.